fbpx
  • Home
  • Study Details
Not currently enrolling

Merck V114 / Prevnar

To Evaluate the Safety, Tolerability, and Immunogenicity of a 4-dose Regimen of V114 (pneumococcal vaccine) in Healthy Infants

Age & Gender

  • 0 years ~ 0 years
  • Male, Female

Contact the Team

Location

Thank you for your interest, but this study is not currently enrolling.

North Carolina (Wake)

Additional Study Information

Principal Investigator

Robert Morgan
UNC Hospitals - UNCPN

Study Topics

Child and Teen Health
Healthy Volunteer or General Population

IRB Number

19-1419

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.